参考文献/References:
[1] GASENKO E, ISAJEVS S, CAMARGO M C, et al. Clinicopathological characteristicsof Epstein-Barr virus-positive gastric cancer in Latvia[J]. European Journal of Gastroenterology & Hepatology, 2019, 31(11): 1328-1333.
[2] CHEN Wanqing，ZHENG Rongshou，BAADE P D, et al. Cancer statistics in China，2015[J]. CA-A Cancer Journal for Clinicians, 2016, 66(2): 115-132.
[3] 国家消化系疾病临床医学研究中心，中华医学会消化内镜学分会 ,中华医学会健康管理学分会，等 .中国早期胃癌筛查流程专家共识意见 (草案 ,2017年 ,上海 )[J].中华消化内镜杂志 ,2018,35( 2 ): 77-83． National Clinical Research Center for Digestive Diseases, Chinese Society of Digestive Endoscopol-ogy, Health Management Branch of the Chinese Medi-cal Association，et al. China consensus on the protocol of early gastric cancer screening (2017, Shanghai) [J]. Chin J Dig Endosc, 2018,35(2): 77-83.
[4] GONG Xuyang，ZHANG Heng. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19 and CEA for young patients with early gastric cancer[J]. Journal of Clinical Laboratory Analysis, 2020,34: e23268.
[5] 王霄腾，吕宾，冀子中．血清幽门螺杆菌抗体联合胃蛋白酶原检测与 OLGA/OLGIM胃炎评价标准在胃癌前病变风险评估中的相关性研究[J].胃肠病学， 2019，24（2）: 71-75． WANG Xiaoteng，Lü Bin, JI Zizhong. Combination of serum Helicobacter pylori antibody with pepsinogens and OLGA/OLGIM staging system for risk assessment of gastric precancerous lesions[J]．Chinese Journal of Gastroenterology, 2019, 24（2）: 71-75．
[6] 赵瑶，刘银梅，胡文斌，等．胃蛋白酶原在癌前病变、胃癌诊断中的应用进展 [J].实用癌症杂志 ,2011, 26(2):205-207, 216. ZHAO Yao, LIU Yinmei, HU Wenbin, et al. Application progress of pepsinogen in diagnosis of precancerous lesions and gastric cancer[J]. The Practical Journal of Cancer, 2011, 26(2):205-207, 216.
[7] 邵翠萍，徐有青．血清 CA724水平与胃恶性肿瘤相关性的 Meta分析 [J].中国医药生物技术 , 2020, 15（2）: 178-182． SHAO Cuiping, XU Youqing . Association between serum CA724 level and gastric carcinoma: a me-ta-analysis[J].Chinese Medicinal Biotechnology, 2020, 15(2):178-182.
[8] 吴烁，金凤岚，肖健存．生长分化因子 15和胃癌抗原 724在胃癌患者血清中的变化及临床意义 [J].中国现代医学杂志 , 2019, 29(23): 30-33. WU Shuo, JIN Fenglan, XIAO Jiancun. Changes and clinical signi.cance of growth differentiation factor 15 and gastric cancer antigen 724 in serum of patients with gastric cancer[J]. China Journal of Modern Medicine, 2019, 29(23): 30-33.
[9] LUO Hai, SHEN Kexin, SUN Hongyan, et al. Cor-relation study between serum neuro-specific enolase and gastric and colorectal cancers[J]. Medicine, 2020, 99(16): e19796.
[10] 刘夏炎，余安运，刘益，等．血清胃蛋白酶原及相关肿瘤标志物与胃癌的相关性研究 [J].现代检验医学杂志 , 2018, 33(5):108-110, 114. LIU Xiayan, YU Anyun, LIU Yi, et al. Relationship between pepsinogen and other tumor markers and gastric cancer [J]. Journal of Modern Laboratory Medicine, 2018, 33(5):108-110, 114.
[11] MARRELLI D, PINTO E, STEFANO A D, et al. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer[J]. The American Journal of Surgery, 2001, 181(1): 16-19.
[12] GU Jinping, HUANG Caihua, HU Xiaomin, et al. Nu-clear magnetic resonance‐based tissue metabolomic analysis clarifies molecular mechanisms of gastric carcinogenesis[J]. Cancer Science, 2020.https://doi. org/10.1111/cas.1443.
[13] 徐风亮，郑加荣，秦燕，等．血清肿瘤标志物联合动态检测对胃癌诊疗的价值 [J].肿瘤研究与临床 , 2016, 28(2):123-126. XU Fengliang, ZHENG Jiarong, QIN Yan, et al. Clinical value of serum tumor markers combined with dynamic detection for diagnosis and treatment in gastric cancer [J]. Cancer Resand Clin, 2016, 28(2):123-126.
[14] 常青霞，黄云锦，王秋波．胃癌血清肿瘤标志物 CEA，CA19-9，CA724的检测及临床意义 [J]．实用临床医药杂志 , 2017, 21(7):174-175. CHANG Qingxia, HUANG Yunjin, WANG Qiubo. Detection and clinical significance of serum tumor markers CEA, CA19-9, CA724 in gastric cancer[J]. Journal of Clinical Medicine in Practice, 2017, 21(7):174-175.
[15] 李果，廖建，周峰．胃癌患者应用 CA724，CEA， CA199肿瘤标志物联合检验的应用分析 [J].实用医院临床杂志，2018, 84(4):208-210. LI Guo, LIAO Jian, ZHOU Feng. Application of joint test of CA724,CEA and CA199 in patients with gastric cancer[J].Practical Journal of Clinical Medicine, 2018, 84(4):208-210.
[16] 刘文超，陈静伟，孙向华． CEA，NSE及 D-二聚体在胃癌患者中的变化及其临床意义 [J].医学综述 , 2017,23(12)2478-2481. LIU Wenchao, CHEN Jingwei, SUN Xianghua. Changes of carcinoembryonic antigen, neuron speci.c enolase, D-dimer in patients with gastric cancer and their clinical significance[J]. Medical Recapitulate , 2017,23(12)2478-2481.
[17] SU Weiwei, ZHOU Bin, QIN Guangming, et al. Low PG I/II ratio as a marker of atrophic gastritis: Association with nutritional and metabolic status in healthy people[J]. Medicine, 2018, 97(20): e10820.
[18] 房国忠，吴红，杨琛．联合检测血清胃蛋白酶原和胸苷激酶 1在胃部疾病诊断中的意义 [J].现代检验families with autosomal recessive Alport syndrome using next generation sequencing technology[J]. Journal of Modern Laboratory Medicine, 2018,33(3):1-4, 7.
[19] 吴杰 , 骆骥才 , 张剑英 , 等 .胃蛋白酶原在胃癌患者血清中变化的意义及其与幽门螺杆菌感染的相关性 [J].中华全科医学 , 2017, 15(6):1010-1012. WU Jie, LUO Jicai, ZHANG Jianying, et al. Variation of serum pepsinogen in gastric cancer patients and its relation to Helicobacter pylori infection [J]. Chinese Journal of General Practice, 2017, 15(6):1010-1012.
[20] 杨朝美，杨晏． PGR与血清肿瘤标记物联合检测在胃癌诊断的临床意义 [J]．中国普通外科杂志， 2018, 27（4）: 523-527． YANG Chaomei, YANG Yan. Clinical significance of combined detection of PGR and serum tumor markers in the diagnosis of gastric cancer[J]. Chinese Journal of General Surgery，2018, 27(4):523-527.
[21] 吴琼，骆钻芳，谢飚，等．血清 Hp-IgG、PGⅠ与 PGR水平对胃癌临床筛查的价值 [J]．热带医学杂志 , 2017, 17(6):736-739. WU Qiong, LUO Zuanfang, XIE Biao, et al. Diagnostic values of Hp-IgG，PG Ⅰ and PGR for the screening of gastric cancer[J]. J Trop Med, 2017, 17(6):736-739.
[22] 卢旬．血清 PGR、CA724和 CA50联合检测在胃癌诊断中的价值 [J]．检验医学与临床，2016，13（10）： 1347-1348． LU Xun. Value of serum PGR, CA724 and CA50 joint detection in diagnosis of gastric cancer [J]. Laboratory Medicine and Clinic, 2016, 13(10):1347-1348.
[23] 吴永伟，赵刚． CEA，CA724，CA199与 PGI，PGII， PGR联合检测在胃癌早期诊断中的价值分析 [J].川北医学院学报，2018,33(6)836-839. WU Yongwei, ZHAO Gang. Analysis on the value of combined detection of CEA, CA724 , CA199 and PGI,PGII,PGR in the early diagnosis of gastric cancer[J]. Journal of North Sichuan Medical College， 2018,33(6)836-839.
相似文献/References:
[1]张 萍a,王红义b,杨迎桂a,等.血清CEA,ProGRP,NSE和CYFRA21-1联合检测在肺癌诊断中的应用研究[J].现代检验医学杂志,2016,31(02):56.[doi:10.3969/j.issn.1671-7414.2016.02.017]
ZHANG Pinga,WANG Hong-yib,YANG Ying-guia,et al.Clinical Application of Combined Detection
of CEA,ProGRP,NSE and CYFRA21-1 in Diagnosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(01):56.[doi:10.3969/j.issn.1671-7414.2016.02.017]
[2]卢美红,鞠少卿,丛 辉,等.南通地区健康人群血清NSE电化学发光法检测参考区间的调查[J].现代检验医学杂志,2018,33(04):59.[doi:10.3969/j.issn.1671-7414.2018.04.015]
LU Mei-hong,JU Shao-qing,CONG Hui,et al.Investigate of Serum NSE Reference Range of Healthy People
in Nantong with Electrochemiluminescence[J].Journal of Modern Laboratory Medicine,2018,33(01):59.[doi:10.3969/j.issn.1671-7414.2018.04.015]
[3]彭 琦a,程少鹏b,陈辅萍a.非小细胞肺癌组织中NSE 的基因表达及与患者临床特征的相关性研究[J].现代检验医学杂志,2020,35(03):36.[doi:10.3969/j.issn.1671-7414.2020.03.008]
PENG Qia,CHENG Shao-pengb,CHEN Fu-pinga.Correlation between NSE Gene Expression and Serum NSE Level in Tumor Tissues
and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2020,35(01):36.[doi:10.3969/j.issn.1671-7414.2020.03.008]
[4]王妮娜,李晓花,陈敏丽,等.肺癌患者血清NSE，SCC，CA125及 CYFRA21-1水平检测在不同病理类型早期诊断和化疗疗效评价中的应用价值[J].现代检验医学杂志,2021,36(01):33.[doi:10.3969/j.issn.1671-7414.2021.01.009]
WANG Ni-na,LI Xiao-hua,CHEN Min-li,et al.Application Value of Serum NSE, SCC, CA125 and CYFRA21-1 in Patients of Lung Cancer for Early Diagnosis and Evaluation of Chemotherapy Efficacy in Patients with Different Pathological Types[J].Journal of Modern Laboratory Medicine,2021,36(01):33.[doi:10.3969/j.issn.1671-7414.2021.01.009]
[5]朱 娇a,孙国才b,刘素荣a,等.食管癌患者血清神经元特异性烯醇化酶与长链非编码RNA ITGA9-AS1水平联合检测的实验诊断价值研究[J].现代检验医学杂志,2021,36(05):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
ZHU Jiaoa,SUN Guo-caib,LIU Su-ronga,et al.Experimental Diagnostic Value of Combined Detection of SerumNeuron-Specific Enolase and Long Non-Coding RNA ITGA9-AS1 inPatients with Esophageal Cancer[J].Journal of Modern Laboratory Medicine,2021,36(01):62.[doi:10.3969/j.issn.1671-7414.2021.05.014]
[6]董旭才,李 斌,曹聪聪,等.临床实验室单标本气动传输系统改进对血清NSE 和Cyfra21-1 检测结果的影响及效果评价[J].现代检验医学杂志,2023,38(04):169.[doi:10.3969/j.issn.1671-7414.2023.04.031]
DONG Xucai,LI Bin,CAO Congcong,et al.Effect and Evaluation of Single Specimen Pneumatic Transmission System Improvement on Serum NSE and Cyfra21-1 Detection in Clinical Laboratory[J].Journal of Modern Laboratory Medicine,2023,38(01):169.[doi:10.3969/j.issn.1671-7414.2023.04.031]